These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1849208)

  • 1. [Trend of anti HCV titer in interferon treatment of chronic hepatitis C].
    Kumada H
    Nihon Rinsho; 1991 Feb; 49(2):451-9. PubMed ID: 1849208
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status.
    Ohnishi K; Nomura F; Nakano M
    Am J Gastroenterol; 1991 Aug; 86(8):1041-9. PubMed ID: 1650129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-A, Non-B hepatitis: advances in diagnosis and therapy].
    Bühler H
    Schweiz Med Wochenschr; 1991 May; 121(20):721-6. PubMed ID: 1647547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
    Kikuchi T; Onji M; Michitaka K; Ohta Y
    Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of determination of anti-HCV antibodies].
    Takase K; Tameda Y; Kosaka Y
    Rinsho Byori; 1994 Oct; 42(10):1003-9. PubMed ID: 7527869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic hepatitis B and C with alpha interferon].
    Hess G
    Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C.
    Quiroga JA; Bosch O; Gonzalez R; Marriott E; Castillo I; Bartolome J; Carreño V
    Gastroenterology; 1992 Oct; 103(4):1285-9. PubMed ID: 1383071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to hepatitis C virus and response to interferon treatment in non-A, non-B chronic hepatitis.
    Taliani G; Lecce R; Clementi C; Furlan C; De Bac C
    J Hepatol; 1991 Mar; 12(2):264-5. PubMed ID: 1646837
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].
    Toyama H; Iwabuchi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):521-7. PubMed ID: 7563813
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sequential monitoring of various HCV-related markers in chronic hepatitis C with interferon treatment].
    Nagayama R; Shoji S; Miyake K
    Nihon Rinsho; 1994 Jul; 52(7):1789-93. PubMed ID: 7521419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitis.
    Kao JH; Lai MY; Chen PJ; Hwang LH; Chen W; Chen DS
    Am J Gastroenterol; 1996 Mar; 91(3):506-10. PubMed ID: 8633499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-hepatitis C antibodies in patients with chronic non-A, non-B hepatitis: relation to disease progression and effect of interferon alpha.
    Yoshioka K; Kakumu S; Hayashi H; Shinagawa T; Wakita T; Ishikawa T; Itoh Y; Takayanagi M
    Am J Gastroenterol; 1991 Oct; 86(10):1495-9. PubMed ID: 1928044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The A to F of viral hepatitis.
    Lancet; 1990 Nov; 336(8724):1158-60. PubMed ID: 1978030
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases.
    Ayoola EA; al-Mofleh IA; al-Faleh FZ; al-Rashed R; Arif MA; Ramia S; Mayet I
    Hepatogastroenterology; 1992 Aug; 39(4):337-9. PubMed ID: 1385286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
    Sakashita H
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune hepatitis with hepatitis C virus markers (anti HCV antibody or HCV-RNA) and interferon therapy].
    Kaji K; Unoura M; Kobayashi K; Nakanuma Y
    Nihon Rinsho; 1994 Jul; 52(7):1865-8. PubMed ID: 7521432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection.
    Johnson RJ; Gretch DR; Yamabe H; Hart J; Bacchi CE; Hartwell P; Couser WG; Corey L; Wener MH; Alpers CE
    N Engl J Med; 1993 Feb; 328(7):465-70. PubMed ID: 7678440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to hepatitis C virus infection after liver transplantation.
    Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB
    Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmunity and HCV].
    Bianchi FB
    Recenti Prog Med; 1993 Nov; 84(11):774-8. PubMed ID: 8290791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.